46 related articles for article (PubMed ID: 29738697)
1. Prognostic role of Gli1 expression in breast cancer: a meta-analysis.
Wang B; Yu T; Hu Y; Xiang M; Peng H; Lin Y; Han L; Zhang L
Oncotarget; 2017 Oct; 8(46):81088-81097. PubMed ID: 29113369
[TBL] [Abstract][Full Text] [Related]
2. Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis.
Wang X; Huang Y; Li L; Dai H; Song F; Chen K
Breast Cancer Res; 2018 Mar; 20(1):18. PubMed ID: 29534738
[TBL] [Abstract][Full Text] [Related]
3. Expression, Significance, and Correlation of Histone Deacetylase 1/RE-1 Silencing Transcription Factor and Neuronal Markers in Glioma.
Shen Y; Ye YR; Tang ZQ
World Neurosurg; 2023 Apr; 172():e267-e277. PubMed ID: 36623722
[TBL] [Abstract][Full Text] [Related]
4. Expression of acetylated histones H3 and H4 and histone deacetylase enzymes HDAC1, HDAC2 and HDAC6 in simple mammary carcinomas of female dogs.
Senhorello ILS; Matiz ORS; Canavari IC; Hernandez GV; Anai LA; Navarrete Ampuero RA; Pazzini JM; Prado CM; Meirelles FV; Vasconcelos RO; Tinucci-Costa EM
Front Genet; 2023; 14():1257932. PubMed ID: 38028583
[TBL] [Abstract][Full Text] [Related]
5. ZFP64 Promotes Gallbladder Cancer Progression through Recruiting HDAC1 to Activate NOTCH1 Signaling Pathway.
He Z; Zhong Y; Hu H; Li F
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760477
[TBL] [Abstract][Full Text] [Related]
6. Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial.
Xu B; Zhang Q; Hu X; Li Q; Sun T; Li W; Ouyang Q; Wang J; Tong Z; Yan M; Li H; Zeng X; Shan C; Wang X; Yan X; Zhang J; Zhang Y; Wang J; Zhang L; Lin Y; Feng J; Chen Q; Huang J; Zhang L; Yang L; Tian Y; Shang H
Acta Pharm Sin B; 2023 May; 13(5):2250-2258. PubMed ID: 37250148
[TBL] [Abstract][Full Text] [Related]
7. CREPT Disarms the Inhibitory Activity of HDAC1 on Oncogene Expression to Promote Tumorigenesis.
Cao Y; Ning B; Tian Y; Lan T; Chu Y; Ren F; Wang Y; Meng Q; Li J; Jia B; Chang Z
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230720
[TBL] [Abstract][Full Text] [Related]
8. The role of histone deacetylase 3 in breast cancer.
Rahbari R; Rasmi Y; Khadem-Ansari MH; Abdi M
Med Oncol; 2022 May; 39(5):84. PubMed ID: 35578147
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Novel Histone Acetylation-Related Gene Signature for Predicting the Prognosis of Ovarian Cancer.
Dai Q; Ye Y
Front Cell Dev Biol; 2022; 10():793425. PubMed ID: 35252174
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Androgen Receptor and Histone Deacetylase 1 Expression on the Prognosis of Ductal Carcinoma
Lee CM; Chung IY; Park Y; Yun KW; Jo HG; Park HJ; Lee HJ; Lee SB; Kim HJ; Ko BS; Lee JW; Son BH; Ahn SH; Kim J
J Breast Cancer; 2020 Dec; 23(6):610-621. PubMed ID: 33408887
[TBL] [Abstract][Full Text] [Related]
11. LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression.
Wang Z; Yu W; Qiang Y; Xu L; Ma F; Ding P; Shi L; Chang W; Mei Y; Ma X
Mol Ther Oncolytics; 2020 Jun; 17():547-561. PubMed ID: 32637573
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of HDAC1, -2 and -3 expression levels in esophageal squamous cell carcinoma.
Li H; Li H; Waresijiang Y; Chen Y; Li Y; Yu L; Li Y; Liu L
Exp Ther Med; 2020 Jul; 20(1):315-324. PubMed ID: 32536999
[TBL] [Abstract][Full Text] [Related]
13. Association of HDAC8 Expression with Pathological Findings in Triple Negative and Non-Triple Negative Breast Cancer: Implications for Diagnosis.
Menbari MN; Rahimi K; Ahmadi A; Mohammadi-Yegane S; Elyasi A; Darvishi N; Hosseini V; Abdi M
Iran Biomed J; 2020 Sep; 24(5):288-94. PubMed ID: 32429642
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinical significance of histone deacetylase 1 expression in breast cancer: A meta-analysis.
Qiao W; Liu H; Liu R; Liu Q; Zhang T; Guo W; Li P; Deng M
Clin Chim Acta; 2018 Aug; 483():209-215. PubMed ID: 29738697
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
Qiao W; Liu H; Guo W; Li P; Deng M
Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase HDAC1 expression correlates with the progression and prognosis of lung cancer: A meta-analysis.
Cao LL; Song X; Pei L; Liu L; Wang H; Jia M
Medicine (Baltimore); 2017 Aug; 96(31):e7663. PubMed ID: 28767587
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.
Pan F; Mao H; Deng L; Li G; Geng P
Int J Clin Exp Pathol; 2014; 7(9):5622-33. PubMed ID: 25337203
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases.
Yan S; Jiao X; Zou H; Li K
Diagn Pathol; 2015 Jun; 10():62. PubMed ID: 26047809
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
